Back to News
Market Impact: 0.35

Synopsys (SNPS) Falls More Steeply Than Broader Market: What Investors Need to Know

SNPSSPYDIAQQQ
Corporate EarningsAnalyst EstimatesCompany FundamentalsTechnology & InnovationAnalyst InsightsCorporate Guidance & OutlookMarket Technicals & Flows
Synopsys (SNPS) Falls More Steeply Than Broader Market: What Investors Need to Know

Synopsys (SNPS) closed down 1.84% to $633.47, underperforming major indices for the day, though it has gained 23.37% over the past month, significantly outpacing its sector and the S&P 500. The chip design software firm is projected to report Q3 2025 EPS of $3.84 (+11.95% YoY) and revenue of $1.77 billion (+15.9% YoY), with full-year estimates also indicating robust growth. Despite these positive growth expectations, SNPS trades at a significant premium with a Forward P/E of 42.77 and PEG ratio of 3.06 compared to industry averages, and its Zacks Consensus EPS estimate saw a minor 0.03% decrease over the last 30 days, resulting in a Zacks Rank #3 (Hold).

Analysis

Synopsys (SNPS) experienced a short-term pullback, closing down 1.84% to $633.47 and underperforming the broader market indices. This daily decline, however, contrasts sharply with its significant recent momentum, evidenced by a 23.37% gain over the last month, which far outpaced the S&P 500's 2.68% increase. Forward-looking consensus estimates support a strong fundamental outlook, with expectations for the upcoming quarter pointing to an 11.95% rise in EPS to $3.84 and a 15.9% increase in revenue to $1.77 billion year-over-year. Full-year forecasts are also robust, projecting earnings growth of 14.32% and revenue growth of 8.03%. Despite these positive growth indicators, the stock's valuation appears stretched. It trades at a Forward P/E of 42.77, a considerable premium to its industry average of 25.14, and its PEG ratio of 3.06 also exceeds the industry average of 2.33. This high valuation, combined with a minor 0.03% downward revision in the consensus EPS estimate over the past month, contributes to its current Zacks Rank of #3 (Hold), suggesting that much of the optimism may already be priced into the stock.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo